192 related articles for article (PubMed ID: 37779005)
21. Characterization of Brain-Targeted Drug Delivery Enhanced by a Combination of Lipid-Based Microbubbles and Non-Focused Ultrasound.
Omata D; Hagiwara F; Munakata L; Shima T; Kageyama S; Suzuki Y; Azuma T; Takagi S; Seki K; Maruyama K; Suzuki R
J Pharm Sci; 2020 Sep; 109(9):2827-2835. PubMed ID: 32534883
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery.
Mørch Ý; Hansen R; Berg S; Åslund AK; Glomm WR; Eggen S; Schmid R; Johnsen H; Kubowicz S; Snipstad S; Sulheim E; Hak S; Singh G; McDonagh BH; Blom H; de Lange Davies C; Stenstad PM
Contrast Media Mol Imaging; 2015; 10(5):356-66. PubMed ID: 25930237
[TBL] [Abstract][Full Text] [Related]
23. Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications.
Upadhyay A; Dalvi SV
Ultrasound Med Biol; 2019 Feb; 45(2):301-343. PubMed ID: 30527395
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design.
Kang ST; Yeh CK
Chang Gung Med J; 2012; 35(2):125-39. PubMed ID: 22537927
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook.
Chowdhury SM; Abou-Elkacem L; Lee T; Dahl J; Lutz AM
J Control Release; 2020 Oct; 326():75-90. PubMed ID: 32554041
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease.
Hu YZ; Zhu JA; Jiang YG; Hu B
Adv Ther; 2009 Apr; 26(4):425-34. PubMed ID: 19381521
[TBL] [Abstract][Full Text] [Related]
27. Lipid-based microbubbles and ultrasound for therapeutic application.
Omata D; Unga J; Suzuki R; Maruyama K
Adv Drug Deliv Rev; 2020; 154-155():236-244. PubMed ID: 32659255
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive update of micro- and nanobubbles as theranostics in oncology.
Jose AD; Wu Z; Thakur SS
Eur J Pharm Biopharm; 2022 Mar; 172():123-133. PubMed ID: 35181491
[TBL] [Abstract][Full Text] [Related]
29. [Progress of ultrasound microbubble contrast technology in the diagnosis and treatment of clinical diseases].
Qiu L; Leng QY; Luo Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):974-8. PubMed ID: 25571727
[TBL] [Abstract][Full Text] [Related]
30. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.
Sennoga CA; Kanbar E; Auboire L; Dujardin PA; Fouan D; Escoffre JM; Bouakaz A
Expert Opin Drug Deliv; 2017 Sep; 14(9):1031-1043. PubMed ID: 27892760
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular drug delivery with ultrasound and microbubbles.
Unger E; Porter T; Lindner J; Grayburn P
Adv Drug Deliv Rev; 2014 Jun; 72():110-26. PubMed ID: 24524934
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-responsive lipid microbubbles for drug delivery: A review of preparation techniques to optimise formulation size, stability and drug loading.
Al-Jawadi S; Thakur SS
Int J Pharm; 2020 Jul; 585():119559. PubMed ID: 32574685
[TBL] [Abstract][Full Text] [Related]
33. Vascular gene transfer and drug delivery in vitro using low-frequency ultrasound and microbubbles.
Yang H; Liu ZH; Liu YY; Lou CC; Ren ZL; Miyoshi H
Acta Pharmacol Sin; 2010 Apr; 31(4):515-22. PubMed ID: 20348943
[TBL] [Abstract][Full Text] [Related]
34. Targeting nanoparticle-conjugated microbubbles combined with ultrasound-mediated microbubble destruction for enhanced tumor therapy.
Chen KW; Hsu PH; Huang HL; Liu HL; Lin YT; Hsu CY; Lin JH; Lin YH
Pharmacol Res; 2022 Dec; 186():106532. PubMed ID: 36334876
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced ultrasound imaging using long-circulating cationic magnetic microbubbles in vitro and in vivo validations.
Liu Y; Lai X; Zhu Y; Guo F; Su L; Arkin G; He T; Xu J; Ran H
Int J Pharm; 2022 Mar; 616():121299. PubMed ID: 34929311
[TBL] [Abstract][Full Text] [Related]
36. Nanoparticle-Coated Microbubbles for Combined Ultrasound Imaging and Drug Delivery.
Jamburidze A; Huerre A; Baresch D; Poulichet V; De Corato M; Garbin V
Langmuir; 2019 Aug; 35(31):10087-10096. PubMed ID: 31033294
[TBL] [Abstract][Full Text] [Related]
37. Microbubbles and their applications in pharmaceutical targeting.
Palekar-Shanbhag P; Chogale MM; Jog SV; Gaikwad SS
Curr Drug Deliv; 2013 Aug; 10(4):363-73. PubMed ID: 23360247
[TBL] [Abstract][Full Text] [Related]
38. Delivery of Liposomes with Different Sizes to Mice Brain after Sonication by Focused Ultrasound in the Presence of Microbubbles.
Shen Y; Guo J; Chen G; Chin CT; Chen X; Chen J; Wang F; Chen S; Dan G
Ultrasound Med Biol; 2016 Jul; 42(7):1499-511. PubMed ID: 27126236
[TBL] [Abstract][Full Text] [Related]
39. Application of low-intensity ultrasound by opening blood-brain barrier for enhanced brain-targeted drug delivery.
Li Q; Tang Z; Zhang Y; Yuan T; Yuan B; Du L; Jin Y
Int J Pharm; 2023 Jul; 642():123191. PubMed ID: 37391108
[TBL] [Abstract][Full Text] [Related]
40. Listening in on the Microbubble Crowd: Advanced Acoustic Monitoring for Improved Control of Blood-Brain Barrier Opening with Focused Ultrasound.
Gorick CM; Sheybani ND; Curley CT; Price RJ
Theranostics; 2018; 8(11):2988-2991. PubMed ID: 29897053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
